Synthesis of Novel 2-(Pyridin-2-yl) Pyrimidine Derivatives and Study of Their Anti-Fibrosis Activity

Yi-Fei Gu,Yue Zhang,Feng-li Yue,Shao-tong Li,Zhuo-qi Zhang,Jing Li,Xu Bai

DOI: https://doi.org/10.3390/molecules25225226

IF: 4.6

2020-11-10

Molecules

Abstract:A pyrimidine moiety exhibiting a wide range of pharmacological activities has been employed in the design of privileged structures in medicinal chemistry. To prepare libraries of novel heterocyclic compounds with potential biological activities, a series of novel 2-(pyridin-2-yl) pyrimidine derivatives were designed, synthesized and their biological activities were evaluated against immortalized rat hepatic stellate cells (HSC-T6). Fourteen compounds were found to present better anti-fibrotic activities than Pirfenidone and Bipy55′DC. Among them, compounds ethyl 6-(5-(p-tolylcarbamoyl)pyrimidin-2-yl)nicotinate (12m) and ethyl 6-(5-((3,4-difluorophenyl)carbamoyl)pyrimidin-2-yl)nicotinate (12q) show the best activities with IC50 values of 45.69 μM and 45.81 μM, respectively. Furthermore, the study of anti-fibrosis activity was evaluated by Picro-Sirius red staining, hydroxyproline assay and ELISA detection of Collagen type I alpha 1 (COL1A1) protein expression. Our study showed that compounds 12m and 12q effectively inhibited the expression of collagen, and the content of hydroxyproline in cell culture medium in vitro, indicating that compounds 12m and 12q might be developed the novel anti-fibrotic drugs.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

This paper aims to solve the problem of anti - fibrosis drug development, especially the anti - fibrosis activity against hepatic stellate cells (HSC - T6). The researchers designed and synthesized novel 2-(pyridin - 2 - yl)pyrimidine derivatives and evaluated the anti - fibrosis activities of these compounds. Through a series of experiments, including MTT cell proliferation inhibition assay, hydroxyproline content determination, Picro - Sirius red staining and ELISA detection of type I collagen (COL1A1) expression, the researchers found that some compounds showed better anti - fibrosis activities than the positive control drugs (such as Pirfenidone and Bipy55′DC). Specifically, the main objectives of the study include: 1. **Design and Synthesis**: Design and synthesize a series of novel 2-(pyridin - 2 - yl)pyrimidine derivatives. 2. **Bioactivity Evaluation**: Evaluate the anti - fibrosis activities of these compounds against HSC - T6 cells. 3. **Mechanism Research**: Explore the anti - fibrosis mechanisms of these compounds through various experimental methods, especially their effects on collagen synthesis and expression. Finally, the study found that compounds 12m and 12q are particularly prominent in inhibiting collagen synthesis and expression and have potential development value.

Synthesis of Novel 2-(Pyridin-2-yl) Pyrimidine Derivatives and Study of Their Anti-Fibrosis Activity

Synthesis and Evaluation of New Pirfenidone Derivatives As Anti-Fibrosis Agents

Design, synthesis and anti-fibrosis activity study of N₁-substituted phenylhydroquinolinone derivatives.

Design, Synthesis and Anti-fibrosis Activity Study of N1-Substituted Phenylhydroquinolinone Derivatives

Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K/AKT/Smad and JAK2/STAT3 pathways

Synthesis and structure-activity relationships of pirfenidone derivatives as anti-fibrosis agents in vitro

One-pot synthesis and pharmacological evaluation of new quinoline/pyrimido-diazepines as pulmonary antifibrotic agents

Design, synthesis and antifibrotic activities of carbohydrate-modified 1-(substituted aryl)-5-trifluoromethyl-2(1H) pyridones.

Synthesis and Anti-Hepaticfibrosis of Glycyrrhetinic Acid Derivatives with Inhibiting COX-2

The design, synthesis, and biological evaluation of novel YC-1 derivatives as potent anti-hepatic fibrosis agents

Discovery and Development of Benzene Sulfonamide Derivatives As Anti-Hepatic Fibrosis Agents

Synthesis and structure-activity relationship of 5-substituent-2(1H)-pyridone derivatives as anti-fibrosis agents.

Design, synthesis and biological evaluation studies of novel anti-fibrosis agents bearing sulfoxide moiety

Design, Synthesis, and Antifibrosis Evaluation of 4-(Benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- Pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-Yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole Derivatives.

Rational design, synthesis and activities of phenanthrene derivatives against hepatic fibrosis

Synthesis, pharmacophores, and mechanism study of pyridin-2(1H)-one derivatives as regulators of translation initiation factor 3A.

Design, synthesis and anti-hepatic fibrosis activity of novel diphenyl vitamin D receptor agonists

Exploring novel A 2A AR antagonists: Design, synthesis, and evaluation of 2,6,9-trisubstituted purine derivatives as promising antifibrotic agents

Synthesis and Biological Evaluation of 4-Oxoquinoline-3-carboxamides Derivatives As Potent Anti-Fibrosis Agents

Design, Synthesis, and Evaluation of Dihydropyrimidine Derivatives as Selective PDE1 Inhibitors for the Treatment of Liver Fibrosis

Design, Synthesis and Anti-Proliferative Activities of 2,6-Substituted Thieno[3,2-d]pyrimidine Derivatives Containing Electrophilic Warheads